Cell Cryopreservation Market to Reach US$ 104.8 Bn by 2035

Driven by Cell & Gene Therapy and Biobanking Expansion

Published on Feb. 12, 2026

Got story updates? Submit your updates here. ›

The global cell cryopreservation market size was valued at US$ 14.9 Bn in 2024 and is projected to reach US$ 104.8 Bn by 2035, expanding at a CAGR of 19.4% from 2025 to 2035. The market is poised for substantial expansion, driven by rapid progress in regenerative medicine, commercialization of advanced cell and gene therapies, expansion of biobanking infrastructure, and increasing demand for long-term biological sample storage across research and clinical settings.

Why it matters

As healthcare systems worldwide shift toward precision medicine and personalized therapeutics, cryopreservation technologies are becoming an indispensable component of modern biomedical workflows. The growing number of clinical trials involving cell-based therapeutics requires efficient storage and transportation of biological materials, fueling demand for advanced cryogenic infrastructure.

The details

Cell cryopreservation refers to the process of preserving living cells at ultra-low temperatures, typically using liquid nitrogen or mechanical freezers, to maintain their structural integrity and biological functionality for extended periods. This process involves the use of cryoprotective agents (CPAs) that prevent ice crystal formation and cellular damage during freezing and thawing cycles. The technology is widely used for preserving stem cells, immune cells, reproductive cells (sperm and oocytes), embryos, and other primary or cultured cell lines. Cryopreservation supports diverse applications including regenerative medicine, drug discovery, oncology research, fertility treatments, and cell-based immunotherapies.

  • The global cell cryopreservation market size was valued at US$ 14.9 Bn in 2024.
  • The market is projected to reach US$ 104.8 Bn by 2035, expanding at a CAGR of 19.4% from 2025 to 2035.

The players

BioLife Solutions, Inc.

In February 2025, BioLife Solutions, Inc. expanded its product range to include advanced cryopreservation media and controlled-rate freezers.

Colder Products Company

In September 2024, Colder Products Company developed Aseptic micro-connectors, compatible with freeze cassettes for processing in gene and cell therapies.

Got photos? Submit your photos here. ›

The takeaway

The rapid expansion of the cell cryopreservation market is driven by the growing demand for advanced cell and gene therapies, the expansion of biobanking initiatives, and the increasing need for reliable long-term storage solutions in the healthcare and research sectors. As the industry continues to evolve, technological advancements in cryogenic storage systems and cryoprotective agents will play a crucial role in supporting the development and commercialization of personalized medicine and regenerative therapies.